Overview

The MPN Congress has been a hallmark event since its establishment in 2001 and has become the premier forum for learning, networking, and advancing knowledge and excellence in the MPN field. 

With an emphasis on robust faculty interaction and active audience engagement, the MPN Congress features a dynamic format that includes a Q&A session following each speaker's presentation. Additionally, participants benefit from numerous networking opportunities and one-on-one discussions, enhancing collaboration and knowledge-sharing among professionals in the field of MPNs. 

The program features a world-renowned faculty and offers CME credit for physicians and CE for nurses and nurse practitioners. 

We are pleased to introduce two new sessions to the program this year, including a debate session, during which experts will discuss contrasting viewpoints on pivotal treatment approaches for PV and myelofibrosis. We are also introducing a novel nurse-led session, designed to provide invaluable insights and expertise in the care and management of MPN patients. 

The MPN Congress accepts abstract submissions and provides an excellent opportunity for fellows, young faculty and others to display their clinical or scientific research in a poster forum during the event. Awards are presented for outstanding abstracts, and the top abstract is presented orally during the general session. 

Learning Objectives

Upon completion of this educational activity, participants should be able to:

• Understand the pathogenesis, clinical manifestations, and diagnostic approaches for the myeloproliferative neoplasms.
• Describe the role and utilization of current approved therapies in the myeloproliferative neoplasms.
• Understand emerging therapeutic agents and treatment modalities for the myeloproliferative neoplasms.
• Discuss the diagnosis and management of uncommon myeloproliferative neoplasms.

Target Audience

This educational activity is intended for hematologists, medical oncologists, translational scientists, and other healthcare professionals (physicians, clinicians, physicians-in-training, oncology nurses, physician assistants, etc.) involved and/or interested in the therapeutic management of patients with myeloproliferative neoplasms and related disorders.

Accreditation

CME FOR PHYSICIANS

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Institute for Medical and Nursing Education, Inc. and Melton Medical Education, LLC . The Institute for Medical and Nursing Education, Inc. is accredited by the ACCME to provide continuing medical education for physicians. IMNE designates this live activity for a maximum of 12.75 AMA PRA Category 1 Credits.™ Physicians should only claim credit commensurate with the extent of their participation in the activity.

CE for NURSES/NPS

Institute for Medical and Nursing Education, Inc. is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. This educational program provides 12.75 contact hours of continuing nursing education credit. If you have any questions regarding the CME or CE credit being offered for this meeting, please contact Steve Weinman, RN at steve.weinman@imne.com

For more information please visit the official event page.